PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and critical care services.

 

Learn more About PAION

Our Mission

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare. 

PAION's Strategy & Partnering

GIAPREZA & XERAVA

Teleconference & webcast

13 January 2021

Replay

news

03/05/2021

PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND...

DGAP-News: PAION AG / Key word(s): Miscellaneous 05.03.2021 /...

Read more
01/29/2021

​​​​​​​PAION RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF BYFAVO(R)...

PAION AG / Key word(s): Miscellaneous ​​​​​​​PAION RECEIVES...

Read more
01/28/2021

PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR...

DGAP-News: PAION AG / Key word(s): Product Launch 28.01.2021 /...

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.